Question 1

What is RAMELTEON used for?

Accepted Answer

RAMELTEON (brand name RAMELTEON) is a Melatonin Agonist indicated for at five weeks in the six week studies (adults and elderly).

Question 2

How does RAMELTEON work?

Accepted Answer

RAMELTEON works through the following mechanism: 12.1 Mechanism of Action Ramelteon is a melatonin receptor agonist with both high affinity for melatonin MT 1 and MT 2 receptors and relative selectivity over the MT 3 receptor. The activity of ramelteon at the MT 1 and MT 2 receptors is believed to contribute to its sleep- promoting properties, as these receptors, acted upon by endogenous melatonin, are thought to be involved in the maintenance of the circadian rhythm underlying the normal sleep-wake cycle. Ramelteon has no appreciable affinity for the GABA receptor complex or for receptors that bind neuropeptides, cytokines, serotonin, dopamine, noradrenaline, acetylcholine, and opiates. Ramelteon also does not interfere with the activity of a number of selected enzymes in a standard panel. The major metabolite of ramelteon, M-II, is pharmacologically active and has approximately one tenth and one fifth the binding affinity of the parent molecule for the human MT 1 and MT 2 receptors, respectively. However, M-II circulates at higher .

Question 3

What are the most common side effects of RAMELTEON?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for RAMELTEON. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is RAMELTEON the same as RAMELTEON?

Accepted Answer

RAMELTEON is a brand name for RAMELTEON. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

RAMELTEON

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations